Meropenem Use and Challenges in Treating Severe Infections in Pakistan Amid Antimicrobial Resistance
Interdisciplinary Perspectives on Infectious Diseases · 2026-01 · 2026 (1)
DOI: 10.1155/ipid/5531329 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Interdisciplinary Perspectives on Infectious Diseases, online erschienen am 19.07.2026. Verfasst von Nasim Akhtar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Pakistan Institute of Medical Sciences, Islamabad, Pakistan, pims.gov.pk. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Meropenem is a broad‐spectrum carbapenem antibiotic essential for treating serious infections including urinary tract infections, pneumonia, sepsis, and meningitis. This narrative review examines meropenem resistance trends and prescribing practices for severe infections in Pakistan highlighting how inappropriate use drives local antimicrobial resistance. Relevant literature was identified through a structured search of PubMed, Scopus, Web of Science, and Google Scholar using predefined keywords. Antimicrobial resistance (AMR) is a global health crisis that complicates treatment of infections caused by multidrug‐resistant Gram‐negative pathogens, including Acinetobacter baumannii , Klebsiella pneumoniae , and E. coli . Pharmacokinetic studies of meropenem show extensive tissue penetration, time‐dependent bactericidal activity, and rapid renal clearance, which contribute to its effectiveness. In critically ill patients, specialized dosing strategies like continuous or extended infusions are recommended to maintain adequate drug levels. Emerging evidence also supports combination therapies (e.g., pairing meropenem with fosfomycin) to improve outcomes against carbapenem‐resistant strains. In Pakistan, these concerns are especially acute: many key pathogens show high resistance rates due to widespread antibiotic overuse and misuse. Regional surveillance indicates that E. coli often remains relatively sensitive to meropenem, whereas Acinetobacter species exhibit alarmingly low susceptibility. Such resistance largely stems from the spread of extended‐spectrum beta‐lactamases (ESBLs) and carbapenemase‐producing organisms, posing serious challenges to clinicians. This underscores the need for data‐driven, context‐specific strategies to guide therapy. Robust surveillance systems are needed to guide empirical therapy, and real‐time resistance monitoring can help prevent treatment failures. The review emphasizes targeted antimicrobial strategies and judicious meropenem use. Ongoing education for healthcare providers and coordinated stewardship programs at local and national levels are also essential to preserve the antibiotic’s clinical utility. Ultimately, sustaining meropenem’s effectiveness in the face of rising AMR requires combined public health efforts, including tailored dosing protocols and localized resistance management, to keep meropenem a reliable option worldwide for treating life‐threatening infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Pakistan Institute of Medical Sciences, Islamabad, Pakistan, pims.gov.pk.
- Department of Pediatrics and Infectious Diseases, Shifa International Hospital, Islamabad, Pakistan, shifa.com.pk.
- Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, shaukatkhanum.org.pk.
- Department of Microbiology, Liaquat National Hospital & Medical College, Karachi, Pakistan.
- Department of General Surgery, Pakistan Institute of Medical Sciences, Islamabad, Pakistan, pims.gov.pk.
- Department of Medicine, College of Family Medicine, Karachi, Pakistan.
ORCID-Profile: Nasim Akhtar, Ejaz Ahmed Khan, Summiya Nizamuddin, Sana Anwar, S H Waqar, Sarmad Iqbal
Zitieren
APA
Akhtar, N., Khan, E. A., Nizamuddin, S., Anwar, S., Waqar, S. H., Faisal, S., & Iqbal, S. (2026). Meropenem Use and Challenges in Treating Severe Infections in Pakistan Amid Antimicrobial Resistance. Interdisciplinary Perspectives on Infectious Diseases, 2026(1). https://doi.org/10.1155/ipid/5531329
Vancouver
Akhtar N, Khan EA, Nizamuddin S, Anwar S, Waqar SH, Faisal S, et al. Meropenem Use and Challenges in Treating Severe Infections in Pakistan Amid Antimicrobial Resistance. Interdisciplinary Perspectives on Infectious Diseases. 2026;2026(1). doi:10.1155/ipid/5531329
BibTeX
@article{Akhtar2026,
author = {Akhtar, Nasim and Khan, Ejaz Ahmed and Nizamuddin, Summiya and Anwar, Sana and Waqar, S H and Faisal, Sarwat and Iqbal, Sarmad},
title = {Meropenem Use and Challenges in Treating Severe Infections in Pakistan Amid Antimicrobial Resistance},
journal = {Interdisciplinary Perspectives on Infectious Diseases},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ipid/5531329}
}
EUVIMED